Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer

Clinical trial NCT07589517 · RECRUITING

Trial details

NCT number: NCT07589517
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic Colorectal Adenocarcinoma Unresectable Colorectal Cancer

Start date: 2026-02-02
Primary completion: 2027-03-14
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.